abstract |
The present invention relates to novel cyclosporins, processes for their preparation, their use as pharmaceuticals and pharmaceutical compositions comprising them. The novel cyclosporins are represented by the compound of formula Ior a pharmaceutically acceptable salt thereof, wherein the letters A to L represent residues of amino acids. |